Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.
British journal of cancer 2013 Jun 108 (12): 2505-15.
Loganayagam A, Arenas Hernandez M, Corrigan A, Fairbanks L, Lewis C M, Harper P, Maisey N, Ross P, Sanderson J D, Marinaki A
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: